Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA — Stella

Recruiting

Back to Rupture of Membranes; Delayed Delivery (Following Spontaneous Rupture) trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Woman's Hospital, Baton Rouge, Louisiana

Key details

Phase

Post-approval study

Sponsor

Woman's

Enrollment target

~34 participants

Started

August 2019

Primary completion

July 2021

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Sex

Female only

Last updated January 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov